Results 151 to 160 of about 89,012 (243)

Primary Hyperparathyroidism From Concurrent Parathyroid Hyperplasia and Ectopic Parathyroid Adenoma: A Case Report. [PDF]

Case Rep Endocrinol
Yao J, Szeto C, Riba C, Nguyen C.
europepmc   +1 more source

Cardiovascular Risk of Romosozumab vs. Teriparatide: A Cohort Study Using Japan’s National Claims Database

Clinical Pharmacology &Therapeutics, Volume 119, Issue 3, Page 721-728, March 2026.
Disproportionality analyses suggested a cardiovascular risk signal for romosozumab, while statistically significant associations were not found in the real‐world database studies. Therefore, a larger comparative study was necessary to examine this signal.
Hotaka Maruyama, Eiko Iwasa, Shinya Watanabe, Tomoaki Hasegawa, Kazuhiro Kajiyama, Taihei Tanaka   +5 more
wiley   +1 more source

Primary Hyperparathyroidism With Brown Tumor-A Case Mistaken as Non-Ossifying Fibroma Resolved by Biochemical and Radiological Correlation. [PDF]

Clin Case Rep
Regmi D, Bhatta U, Bhattarai M, Jha S, Baral A.   +4 more
europepmc   +1 more source

Embryonic Hormetic Priming Modulates Later‐Life Thermal Tolerance

Ecology and Evolution, Volume 16, Issue 3, March 2026.
This study investigates how early‐life thermal environments affect later thermal tolerance in the black‐lip pearl oyster, Pinctada margaritifera. Developmental thermal priming had contrasting, family‐specific effects on thermal tolerance, with conserved stress‐response pathways but evidence of priming‐induced regulatory network reorganization.
K. Lugue, C. J. Monaco, L. Benestan, E. Vigouroux, M. Sham Koua, J. Vidal‐Dupiol, G. Mitta, J. Le Luyer   +7 more
wiley   +1 more source

Parathyroid carcinoma as an overlooked etiology of osteoporosis in postmenopausal women: a case report. [PDF]

Front Endocrinol (Lausanne)
Su J, Lei S, Jin M, Hu H, He W.
europepmc   +1 more source

The Influence of Aerobic and Strength Training on Oxidative Stress and Antioxidant Status in Hemodialysis Patients: A Randomized Controlled Trial

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aims To investigate the effects of a 6‐month supervised, personalized combined aerobic and resistance training program on oxidative stress, antioxidant capacity, infection‐related biomarkers, and body composition in maintenance hemodialysis (MHD) patients.
Yuwei Chen, Lu Yin, Xinzhou Zhang, Xue Zheng, Lijuan Lan, Liping Sun   +5 more
wiley   +1 more source

Predictors of Maternal Vitamin D Deficiency and Associated Adverse Neonatal Outcomes in Eastern Uganda: A Cross‐Sectional Study

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aims Vitamin D deficiency in pregnancy has been linked to adverse maternal and neonatal outcomes, but evidence from Uganda is limited. We estimated the prevalence of maternal vitamin D deficiency at delivery, identified associated factors, and assessed immediate neonatal outcomes.
Hussein Mire Hamdi, Marie Pascaline Sabine Ishimwe, Theodore Nteziyaremye, Kasujja Musa, Sowda Abdikarim Sheikh Isse, Geoffrey Okot, Emmanuel Okurut, Damulira Adam, Hassan Abdullahi Hafsa, Mohamud Mohamed Sadia, Ramla Abdi Ali, Adam Abdrahim Suliman Ebaid, Amos Muhumuza, Maxwell Okello, Ahmed Kiswezi Kazigo, Theoneste Hakizimana   +15 more
wiley   +1 more source

[18F]Fluorocholine PET/CT in a 15-year-old patient suggested HPT-JT syndrome with active cemento-ossifying fibroma. [PDF]

EJNMMI Res
Serani F, Lacognata CS, Torresan F, Iacobone M, Cecchin D.   +4 more
europepmc   +1 more source

Mitochondrial Abnormalities of T Lymphocytes in Patients With Maintenance Hemodialysis

Immunity, Inflammation and Disease, Volume 14, Issue 3, March 2026.
ABSTRACT Objective To investigate the characteristics of T lymphocyte subsets and mitochondrial function in hemodialysis patients and to explore the effect of hemodialysis on these parameters. Methods Patients with end‐stage renal disease (ESRD) from July 2023 to June 2024, who underwent mitochondrial function detection of T lymphocyte subsets, were ...
Chunlei Luo, Sizeng Bao, Xueyan Bian, Lingling Bao, Chunyang Ji, Jianwei Ma, Jiancheng Huang   +6 more
wiley   +1 more source

Pituitary Apoplexy Following Gonadotropin‐Releasing Hormone Agonist Administration for Prostate Cancer

IJU Case Reports, Volume 9, Issue 2, March 2026.
ABSTRACT Introduction Pituitary apoplexy represents an uncommon endocrine emergency with potentially life‐threatening consequences. Gonadotropin‐releasing hormone agonist used for prostate cancer has the potential to induce pituitary apoplexy, particularly in the setting of a preexisting pituitary adenoma.
Masaaki Fujimura, Takahiro Shimizu, Shinichi Sakamoto, Hiroaki Sato, Hiroyoshi Suzuki, Kazuo Mikami   +5 more
wiley   +1 more source